Доступ предоставлен для: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems
Главный редактор: Mandip Sachdeva Singh (open in a new tab)

Выходит 6 номеров в год

ISSN Печать: 0743-4863

ISSN Онлайн: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Particulate Delivery Systems for Vaccines

Том 22, Выпуск 2, 2005, pp. 151-214
DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i2.20
Get accessGet access

Краткое описание

This review focuses on the use of particulate delivery systems for the purposes of immunization. This includes poly(lactide-co-glycolide) (PLGA), ISCOMs, liposomes, niosomes, virosomes, chitosan, and other biodegradable polymers. These systems are evaluated in terms of their use as carriers for protein subunit and DNA vaccines. There is an extensive focus on recent literature, the understanding of biological interactions, and relation of this to our present understanding of immunological mechanisms of action. In addition, there is consideration of formulation techniques including emulsification, solvent diffusion, DNA complexation, and entrapment. The diversity of formulation strategies presented is a testament to the exponential growth and interest in the area of vaccine delivery systems. A case study for the application of particulate vaccine carriers is assessed in terms of vaccine development and recent insights into the possible design and application of vaccines against two of the most important pathogens that threaten mankind and for which there is a significant need: Mycobacterium tuberculosis and human immunodeficiency virus. This review addresses the rationale for the use of particulate delivery systems in vaccine design in the context of the diversity of carriers for DNA- and protein-based vaccines and their potential for application in terms of the critical need for effective vaccines.

ЦИТИРОВАНО В
  1. McNeil Sarah E, Perrie Yvonne, Gene delivery using cationic liposomes, Expert Opinion on Therapeutic Patents, 16, 10, 2006. Crossref

  2. Santander-Ortega Manuel J., Csaba Noemi, González Lisette, Bastos-González Delfina, Ortega-Vinuesa Juan L., Alonso Maria J., Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics, Colloid and Polymer Science, 288, 2, 2010. Crossref

  3. Gordon Sarah, Saupe Anne, McBurney Warren, Rades Thomas, Hook Sarah, Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery, Journal of Pharmacy and Pharmacology, 60, 12, 2010. Crossref

  4. Alpar H Oya, Papanicolaou Irene, Bramwell Vincent W, Strategies for DNA vaccine delivery, Expert Opinion on Drug Delivery, 2, 5, 2005. Crossref

  5. Hurtado-López Pepi, Murdan Sudaxshina, An investigation into the adjuvanticity and immunogenicity of zein microspheres being researched as drug and vaccine carriers, Journal of Pharmacy and Pharmacology, 58, 6, 2010. Crossref

  6. Chiarella Pieranna, Massi Emanuela, De Robertis Mariangela, Signori Emanuela, Fazio Vito Michele, Adjuvants in vaccines and for immunisation: current trends, Expert Opinion on Biological Therapy, 7, 10, 2007. Crossref

  7. Bramwell Vincent W, Perrie Yvonne, Particulate delivery systems for vaccines: what can we expect?, Journal of Pharmacy and Pharmacology, 58, 6, 2010. Crossref

  8. Smith Alan M., Harris Jonathan J., Shelton Richard M., Perrie Yvonne, 3D culture of bone-derived cells immobilised in alginate following light-triggered gelation, Journal of Controlled Release, 119, 1, 2007. Crossref

  9. Perrie Yvonne, Mohammed Afzal R., Kirby Daniel J., McNeil Sarah E., Bramwell Vincent W., Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens, International Journal of Pharmaceutics, 364, 2, 2008. Crossref

  10. Bramwell Vincent W., Perrie Yvonne, The rational design of vaccines, Drug Discovery Today, 10, 22, 2005. Crossref

  11. Bhowmik Tuhin, D’Souza Bernadette, Shashidharamurthy Rangaiah, Oettinger Carl, Selvaraj Periasamy, D’Souza Martin J., A novel microparticulate vaccine for melanoma cancer using transdermal delivery, Journal of Microencapsulation, 28, 4, 2011. Crossref

  12. De Temmerman Marie-Luce, Rejman Joanna, Demeester Jo, Irvine Darrell J., Gander Bruno, De Smedt Stefaan C., Particulate vaccines: on the quest for optimal delivery and immune response, Drug Discovery Today, 16, 13-14, 2011. Crossref

  13. Gordon Sarah, Young Katherine, Wilson Rachel, Rizwan Shakila, Kemp Roslyn, Rades Thomas, Hook Sarah, Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems, Journal of Liposome Research, 22, 3, 2012. Crossref

  14. Mohammed Afzal R., Bramwell Vincent W., Kirby Daniel J., McNeil Sarah E., Perrie Yvonne, Increased potential of a cationic liposome-based delivery system: Enhancing stability and sustained immunological activity in pre-clinical development, European Journal of Pharmaceutics and Biopharmaceutics, 76, 3, 2010. Crossref

  15. Manca Maria-Letizia, Mourtas Spyridon, Dracopoulos Vassileios, Fadda Anna Maria, Antimisiaris Sophia G., PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery?, Colloids and Surfaces B: Biointerfaces, 62, 2, 2008. Crossref

  16. Fischer Stefan, Uetz-von Allmen Edith, Waeckerle-Men Ying, Groettrup Marcus, Merkle Hans P., Gander Bruno, The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles, Biomaterials, 28, 6, 2007. Crossref

  17. Lim Yong Taik, Shim Sang-Mu, Noh Young-Woock, Lee Kyung-Soon, Choi Doo-Yeol, Uyama Hiroshi, Bae Hee Ho, Kim Ji Hyun, Hong Kwan Soo, Sung Moon-Hee, Poo Haryoung, Bioderived Polyelectrolyte Nanogels for Robust Antigen Loading and Vaccine Adjuvant Effects, Small, 7, 23, 2011. Crossref

  18. Pushko Peter, Tumpey Terrence M., Van Hoeven Neal, Belser Jessica A., Robinson Robin, Nathan Margret, Smith Gale, Wright D. Craig, Bright Rick A., Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza, Vaccine, 25, 21, 2007. Crossref

  19. Sharma Sameer, Mukkur Trilochan K.S., Benson Heather A.E., Chen Yan, Enhanced Immune Response Against Pertussis Toxoid by IgA-Loaded Chitosan–Dextran Sulfate Nanoparticles, Journal of Pharmaceutical Sciences, 101, 1, 2012. Crossref

  20. Pusic Kae, Xu Hengyi, Stridiron Andrew, Aguilar Zoraida, Wang Andrew, Hui George, Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies, Vaccine, 29, 48, 2011. Crossref

  21. Ho Jenny, Huang Yi, Danquah Michael K., Wang Huanting, Forde Gareth M., Synthesis of biodegradable polymer–mesoporous silica composite microspheres for DNA prime-protein boost vaccination, European Journal of Pharmaceutical Sciences, 39, 5, 2010. Crossref

  22. Pai Kasturi Sudhir, Qin Hong, Thomson Kassandra S., El-Bereir Shihab, Cha Soung-chul, Neelapu Sattva, Kwak Larry W., Roy Krishnendu, Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles, Journal of Controlled Release, 113, 3, 2006. Crossref

  23. Aguilar J.C., Rodríguez E.G., Vaccine adjuvants revisited, Vaccine, 25, 19, 2007. Crossref

  24. Jain Vikas, Vyas Suresh P., Kohli Dharmveer V., Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives, Nanomedicine: Nanotechnology, Biology and Medicine, 5, 3, 2009. Crossref

  25. Vangala Anil, Bramwell Vincent W., McNeil Sarah, Christensen Dennis, Agger Else Marie, Perrie Yvonne, Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen, Journal of Controlled Release, 119, 1, 2007. Crossref

  26. Mohammed Afzal R., Bramwell Vincent W., Coombes Allan G.A., Perrie Yvonne, Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products, Methods, 40, 1, 2006. Crossref

  27. Cetin Emel Oyku, Gundogdu Evren, Kirilmaz Levent, Novel microparticle drug delivery systems based on chitosan and Eudragit®RSPM to enhance diltiazem hydrochloride release property, Pharmaceutical Development and Technology, 17, 6, 2012. Crossref

  28. Myschik Julia, McBurney Warren T., Rades Thomas, Hook Sarah, Immunostimulatory lipid implants containing Quil-A and DC-cholesterol, International Journal of Pharmaceutics, 363, 1-2, 2008. Crossref

  29. Irvine D.J., Jewell C.M., Vaccine and Immunotherapy Delivery, in Comprehensive Biomaterials, 2011. Crossref

  30. Zhang Wenbao, McManus Donald P., Vaccination of dogs against Echinococcus granulosus: a means to control hydatid disease?, Trends in Parasitology, 24, 9, 2008. Crossref

  31. Rice-Ficht Allison C, Arenas-Gamboa Angela M, Kahl-McDonagh Melissa M, Ficht Thomas A, Polymeric particles in vaccine delivery, Current Opinion in Microbiology, 13, 1, 2010. Crossref

  32. De Temmerman Marie-Luce, Rejman Joanna, Lucas Bart, Vandenbroucke Roosmarijn E., Libert Claude, Demeester Jo, De Smedt Stefaan C., Modulation of Dendritic Cells by Lipid Grafted Polyelectrolyte Microcapsules, Advanced Functional Materials, 22, 20, 2012. Crossref

  33. D’Souza Bernadette, Bhowmik Tuhin, Shashidharamurthy Rangaiah, Oettinger Carl, Selvaraj Periasamy, D’Souza Martin, Oral microparticulate vaccine for melanoma using M-cell targeting, Journal of Drug Targeting, 20, 2, 2012. Crossref

  34. Alpar H. Oya, Bramwell Vincent W., Veronesi Eva, Darpel Karin E., Pastoret Paul-Pierre, Mertens Peter P.C., Bluetongue virus vaccines past and present, in Bluetongue, 2009. Crossref

  35. Correia-Pinto J.F., Csaba N., Alonso M.J., Vaccine delivery carriers: Insights and future perspectives, International Journal of Pharmaceutics, 440, 1, 2013. Crossref

  36. León-Rodríguez L., Luzardo-Álvarez A., Blanco-Méndez J., Lamas J., Leiro J., A vaccine based on biodegradable microspheres induces protective immunity against scuticociliatosis without producing side effects in turbot, Fish & Shellfish Immunology, 33, 1, 2012. Crossref

  37. Handké Nadège, Ficheux Damien, Rollet Marion, Delair Thierry, Mabrouk Kamel, Bertin Denis, Gigmes Didier, Verrier Bernard, Trimaille Thomas, Lysine-tagged peptide coupling onto polylactide nanoparticles coated with activated ester-based amphiphilic copolymer: A route to highly peptide-functionalized biodegradable carriers, Colloids and Surfaces B: Biointerfaces, 103, 2013. Crossref

  38. León-Rodríguez L., Luzardo-Álvarez A., Blanco-Méndez J., Lamas J., Leiro J., Biodegradable microparticles covalently linked to surface antigens of the scuticociliate parasite P. dicentrarchi promote innate immune responses in vitro, Fish & Shellfish Immunology, 34, 1, 2013. Crossref

  39. Rattanapak Teerawan, Young Katie, Rades Thomas, Hook Sarah, Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration, Journal of Pharmacy and Pharmacology, 64, 11, 2012. Crossref

  40. De Temmerman Marie-Luce, Rejman Joanna, Vandenbroucke Roosmarijn E., De Koker Stefaan, Libert Claude, Grooten Johan, Demeester Jo, Gander Bruno, De Smedt Stefaan C., Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen, Journal of Controlled Release, 158, 2, 2012. Crossref

  41. Denis F., Hantz S., Alain S., Immunité et vaccinations antivirales : exemple de la muqueuse respiratoire, Antibiotiques, 9, 2, 2007. Crossref

  42. Yeboah Kwame G., Akande Janet, Addo Richard T., Siwale Rodney C., Aninkorah-Yeboah Kwesi, Siddig Aladin, In vitroandex vivocharacterization of lectin-labeledMycobacterium tuberculosisantigen-containing microspheres for enhanced oral delivery, Journal of Drug Targeting, 22, 1, 2014. Crossref

  43. Dehghan Solmaz, Tafaghodi Mohsen, Bolourieh Tina, Mazaheri Vahideh, Torabi Ali, Abnous Khalil, Tavassoti Kheiri Masoumeh, Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants, International Journal of Pharmaceutics, 475, 1-2, 2014. Crossref

  44. Kirby Daniel J., Rosenkrands Ida, Agger Else M., Andersen Peter, Coombes Allan G. A., Perrie Yvonne, PLGA microspheres for the delivery of a novel subunit TB vaccine, Journal of Drug Targeting, 16, 4, 2008. Crossref

  45. Ortega-Oller Inmaculada, Padial-Molina Miguel, Galindo-Moreno Pablo, O’Valle Francisco, Jódar-Reyes Ana Belén, Peula-García Jose Manuel, Bone Regeneration from PLGA Micro-Nanoparticles, BioMed Research International, 2015, 2015. Crossref

  46. Myschik Julia, Mcburney Warren T., Hennessy Tania, Phipps-Green Amanda, Rades Thomas, Hook Sarah, Immunostimulatory biodegradable implants containing the adjuvant Quil-A—Part II:In vivoevaluation, Journal of Drug Targeting, 16, 3, 2008. Crossref

  47. Kirby Daniel J., Rosenkrands Ida, Agger Else M., Andersen Peter, Coombes Allan G. A., Perrie Yvonne, Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres, Journal of Drug Targeting, 16, 7-8, 2008. Crossref

  48. Ghimire Tirth Raj, The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm, SpringerPlus, 4, 1, 2015. Crossref

  49. Kastner Elisabeth, Hussain M Jubair, Bramwell Vincent W, Christensen Dennis, Perrie Yvonne, Correlating liposomal adjuvant characteristics to in-vivo cell-mediated immunity using a novel M ycobacterium tuberculosis fusion protein: a multivariate analysis study, Journal of Pharmacy and Pharmacology, 67, 3, 2015. Crossref

  50. Pouyanfard Somayeh, Bamdad Taravat, Hashemi Hamidreza, Bandehpour Mojgan, Kazemi Bahram, Ahmad Aamir, Induction of Protective Anti-CTL Epitope Responses against HER-2-Positive Breast Cancer Based on Multivalent T7 Phage Nanoparticles, PLoS ONE, 7, 11, 2012. Crossref

  51. Rietscher René, Czaplewska Justyna A., Majdanski Tobias C., Gottschaldt Michael, Schubert Ulrich S., Schneider Marc, Lehr Claus-Michael, Impact of PEG and PEG- b -PAGE modified PLGA on nanoparticle formation, protein loading and release, International Journal of Pharmaceutics, 500, 1-2, 2016. Crossref

  52. Liu Qi, Jia Jilei, Yang Tingyuan, Fan Qingze, Wang Lianyan, Ma Guanghui, Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses, Small, 12, 13, 2016. Crossref

  53. Akande Janet, Yeboah Kwame G., Addo Richard T., Siddig Aladin, Oettinger Carl W., D'Souza Martin J., Targeted delivery of antigens to the gut-associated lymphoid tissues: 2.Ex vivoevaluation of lectin-labelled albumin microspheres for targeted delivery of antigens to the M-cells of the Peyer's patches, Journal of Microencapsulation, 27, 4, 2010. Crossref

  54. Lv Meng, Li Sha, Zhao Haijie, Wang Kewei, Chen Qianqian, Guo Zhong, Liu Zonghua, Xue Wei, Redox-responsive hyperbranched poly(amido amine) and polymer dots as a vaccine delivery system for cancer immunotherapy, Journal of Materials Chemistry B, 5, 48, 2017. Crossref

  55. Arab Atefeh, Nicastro Jessica, Slavcev Roderick, Razazan Atefeh, Barati Nastaran, Nikpoor Amin Reza, Brojeni Amir Abbas Momtazi, Mosaffa Fatemeh, Badiee Ali, Jaafari Mahmoud Reza, Behravan Javad, Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response, Immunologic Research, 66, 1, 2018. Crossref

  56. ElBayoumi Tamer A., Torchilin Vladimir P., Current Trends in Liposome Research, in Liposomes, 605, 2010. Crossref

  57. Kirby Daniel J., Kaur Randip, Perrie Yvonne, Formulation and Characterisation of PLGA Microspheres as Vaccine Adjuvants, in Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines, 2013. Crossref

  58. Feng Zhongtao, Yi Xin, Hajavi Jafar, New and old adjuvants in allergen‐specific immunotherapy: With a focus on nanoparticles, Journal of Cellular Physiology, 236, 2, 2021. Crossref

  59. Wilkhu Jitinder, McNeil Sarah E, Kirby Daniel J, Perrie Yvonne, Formulation design considerations for oral vaccines, Therapeutic Delivery, 2, 9, 2011. Crossref

  60. Fischer Nicholas O., Infante Ernesto, Ishikawa Tomohiro, Blanchette Craig D., Bourne Nigel, Hoeprich Paul D., Mason Peter W., Conjugation to Nickel-Chelating Nanolipoprotein Particles Increases the Potency and Efficacy of Subunit Vaccines to Prevent West Nile Encephalitis, Bioconjugate Chemistry, 21, 6, 2010. Crossref

  61. Cohen Joel A., Beaudette Tristan T., Tseng William W., Bachelder Eric M., Mende Ines, Engleman Edgar G., Fréchet Jean M. J., T-Cell Activation by Antigen-Loaded pH-Sensitive Hydrogel Particles in Vivo: The Effect of Particle Size, Bioconjugate Chemistry, 20, 1, 2009. Crossref

  62. Meziani Mohammed J., Pathak Pankaj, Desai Tarang, Sun Ya-Ping, Supercritical Fluid Processing of Nanoscale Particles from Biodegradable and Biocompatible Polymers, Industrial & Engineering Chemistry Research, 45, 10, 2006. Crossref

  63. Giddam Ashwini Kumar, Zaman Mehfuz, Skwarczynski Mariusz, Toth Istvan, Liposome-based delivery system for vaccine candidates: constructing an effective formulation, Nanomedicine, 7, 12, 2012. Crossref

  64. Winter Gerhard, Myschik Julia, Formulation Strategies for Recombinant Protein and Related Biotech Drugs, in Pharmaceutical Biotechnology, 2012. Crossref

  65. Phillips Brett, Nylander Karen, Harnaha Jo, Machen Jennifer, Lakomy Robert, Styche Alexis, Gillis Kimberly, Brown Larry, Lafreniere Debra, Gallo Michael, Knox Janet, Hogeland Kenneth, Trucco Massimo, Giannoukakis Nick, A Microsphere-Based Vaccine Prevents and Reverses New-Onset Autoimmune Diabetes, Diabetes, 57, 6, 2008. Crossref

  66. McDowell Arlene, Delivery Systems for Wildlife, in Long Acting Animal Health Drug Products, 2013. Crossref

1318 Просмотры статей 97 Загрузка статей Метрики
1318 ПРОСМОТРЫ 97 ЗАГРУЗКИ 66 Crossref ЦИТАТЫ Google
Scholar
ЦИТАТЫ

Статьи с похожим содержанием:

Colloidal Carriers: A Rising Tool for Therapy of Tuberculosis Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 4
Suresh P. Vyas, Manish K. Gupta, Swati Gupta, Pankaj Kumar
Functional Polymeric Nanoparticles: An Efficient and Promising Tool for Active Delivery of Bioactives Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.23, 2006, issue 4
Senthilkumar Murugesan, Tathagata Dutta, Abhay Asthana, Manoj Tare, Surbhi Saraf, Narendra Kumar Jain, Vijayaraj Rajkumar, Manoj Nahar, Dinesh Mishra
Role of Block Copolymer Nanoconstructs in Cancer Therapy Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 2
H. G. Agrawal, K. K. Upadhyay, C. Schatz, Sebastian Lecommandoux, J. F. Le Meins, Ambikanandan Misra, C. Upadhyay
Self-Emulsifying Drug Delivery Systems (SEDDS): Formulation Development, Characterization, and Applications Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 5
Shantanu Bandopadhyay, Ramandeep Singh, Bhupinder Singh, Rishi Kapil, Om Parkash Katare
Nanosuspensions in Drug Delivery: Recent Advances, Patent Scenarios, and Commercialization Aspects Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.28, 2011, issue 5
Krutika Sawant, Kailash C. Petkar, Sandip S. Chavhan
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain